FDC Ltd

FDC Annual General Meeting

FDC Limited issued a corrigendum to its 86th AGM notice, correcting the e-voting cut-off date to September 17, 2026. This also updates the book closure dates.

FDC Promoter Selling (Off-Market)

Promoter Nandan Mohan Chandavarkar gifted 50,30,086 shares of FDC Ltd via off-market inter-se transfers. His personal stake decreased from 3.10% to 0.01%.

FDC Business Update

FDC Limited submitted its Business Responsibility and Sustainability Report for the financial year 2025-26. This filing complies with regulation 34 of SEBI (LODR) regulations.

FDC Annual Report

FDC Limited has filed its Annual Report for the financial year 2025-26, and the 86th AGM is scheduled for September 24, 2026.

FDC Annual General Meeting

FDC Limited issued a notice for its 86th Annual General Meeting to be held on September 24, 2026. The meeting includes agenda items for financial statement adoption.

FDC Annual General Meeting

FDC Limited has scheduled its 86th Annual General Meeting for September 24, 2026, to approve financial statements and ratify the cost auditor's remuneration.

Value

₹0.04 Cr

FDC Legal & Regulatory

FDC Limited received an interim stay from the Delhi High Court regarding an FSSAI notice, allowing 8 months to exhaust existing stock with specific product labels.

FDC Regulatory Approval

FDC Limited's subsidiary, FDC International Limited, received marketing authorization from MHRA, UK for Atropine 1.0% eye drops. This regulatory approval enables product commercialization in the United Kingdom.

FDC Results Update

FDC Limited reported its Q1 FY27 consolidated results in a press release. The company highlighted Revenue of Rs. 668 crore and PAT of Rs. 132 crore.

FDC Q1 FY27 Results: Net Profit ₹132.5 Cr, Up 9.2% YoY

FDC Ltd reported revenue from operations of ₹667.7 Cr (+3.0% YoY) and net profit of ₹132.5 Cr (+9.2% YoY) for Q1 FY27.

Key figure

Net profit ₹132.5 Cr · +9.2% YoY

FDC Board Meeting Date

FDC Limited scheduled a board meeting for August 5, 2026. The board will consider the quarterly unaudited financial results for June 2026.

FDC Promoter Buying (Off-Market)

Mohan Anand Chandavarkar Trust acquired 26,70,316 shares (1.64%) of FDC Limited through an off-market gift. This inter-se transfer occurs within the promoter group.

FDC Promoter Selling (Off-Market)

Promoter Nandan Mohan Chandavarkar gifted 50,30,086 shares (3.09% stake) to family trusts. The off-market inter-se transfer reduces his direct holding to 0.01%.

FDC Adverse Business Impact

Maharashtra FDA officials seized stock of FDC's 'Enerzal' product due to alleged misbranding. The company reports no material financial impact and plans legal recourse.

FDC Annual General Meeting

FDC Limited shareholders approved the appointment of Mr. Kishore Mukund Saletore as an Independent Director. The resolution passed with a 99.77% majority via postal ballot.

FDC Other Announcement

FDC Limited filed its Annual Secretarial Compliance Report for the financial year 2026. The auditor reported full compliance with SEBI regulations with no deviations or penalties.

FDC Results Update

FDC Limited reported FY26 revenue of ₹2,171 Crore, reflecting 3.0% annual growth. Q4 performance was robust with 18.9% revenue growth and significantly improved EBITDA margins.

Value

₹2,171 Cr

FDC Results Update

FDC Limited reported Q4 FY26 revenue of ₹585 Crore, achieving 18.9% Y-o-Y growth. Robust performance across domestic and export segments drove significant margin expansion to 18.2%.

FDC Q4 FY26 Results: Net Profit ₹103.4 Cr, Up 167.2% YoY

FDC Ltd reported revenue from operations of ₹584.8 Cr (+18.9% YoY) and net profit of ₹103.4 Cr (+167.2% YoY) for Q4 FY26.

Key figure

Net profit ₹103.4 Cr · +167.2% YoY

FDC Financial Results

FDC Limited reported annual standalone total income of ₹2,237.33 Crore for FY2026. The board also re-appointed cost and tax auditors for the upcoming financial year.

Value

₹2,237 Cr

FDC Board Meeting Date

FDC Limited scheduled a board meeting for May 27, 2026, to approve audited financial results. This provides advance notice for upcoming performance disclosures.

FDC Regulatory Approval

FDC Limited received U.S.FDA ANDA approval for Cefixime Oral Suspension USP in two strengths. This regulatory milestone enables the company to market these products in the US.

FDC Board Meeting Date

FDC Limited scheduled a board meeting on May 27, 2026, to approve audited annual financial results. The trading window remains closed until May 29, 2026.

FDC Annual General Meeting

FDC Limited issued a corrigendum clarifying that the appointment of Mr. Kishore Mukund Saletore requires a Special Resolution. This corrects an inadvertent mention of an Ordinary Resolution.

FDC Debt & Borrowing

FDC Limited has confirmed it does not meet the SEBI criteria for 'Large Corporate' status as of March 31, 2026. The company reported nil outstanding long-term borrowings in its annual disclosure. This regulatory filing complies with SEBI's framework for fund raising via debt securities.

FDC Annual General Meeting

FDC Limited has issued a Postal Ballot Notice to seek shareholder approval for the appointment of Mr. Kishore Mukund Saletore as an Independent Director for five years. Remote e-voting commences on April 28, 2026, and ends on May 27, 2026. This process ensures regulatory compliance and corporate governance for the director's appointment.

FDC Annual General Meeting

FDC Limited is seeking shareholder approval via postal ballot for the appointment of Mr. Kishore Saletore as an Independent Director for a five-year term. E-voting starts April 28, 2026, and ends May 27, 2026. Results will be declared by May 29, 2026.

Execution

5 years

FDC Annual General Meeting

FDC Limited is seeking shareholder approval via postal ballot for the appointment of Mr. Kishore Saletore as a director for a five-year term. Remote e-voting is scheduled from April 28 to May 27, 2026, with results expected by May 29, 2026. Mr. Sanjay Dholakia has been appointed as the scrutinizer for the process.